Loading organizations...
Loading organizations...
Biopharmaceutical company specializing in CAR-T therapy for solid tumors.
AffyImmune Therapeutics has raised $20.0M across 1 funding round.
AffyImmune Therapeutics has raised $20.0M in total across 1 funding round.
AffyImmune Therapeutics has raised $20.0M in total across 1 funding round.
AffyImmune Therapeutics's investors include Elaine Yang.
AffyImmune Therapeutics has raised $20.0M across 1 funding round. Most recently, it raised $20.0M Series A in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 8, 2021 | $20.0M Series A | Elaine Yang |